Perbedaan Nitrasanata Dharma Tbk. dan Organon Pharma Indonesia Tbk.: Nitrasanata Dharma Tbk. diperdagangkan di Rp1.340 (kapitalisasi pasar 4,39 T, volume 24 jam 1,83 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Nitrasanata Dharma Tbk. jauh lebih besar — sekitar 42× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| JECX | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 4,39 T | 104,4 M |
Volume | 1,83 jt | — |
Lot | 18,28 rb | — |
Perputaran | 2,42 M | — |
Harga Rata-rata | 1.326,31 | — |
Nilai Transaksi | 2,42 M | — |
Harga Ekuilibrium Indikatif | 1.340 | — |
Volume Ekuilibrium Indikatif | 201 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Nitrasanata Dharma Tbk (the Company) was established based on Notarial Deed No. 526 of Richardus Nangkih Sinulingga, S.H., dated November 28, 1990. The Company started its commercial operations in 1990. PT Magna Selaras Lestari is the controlling entity of the Company, and Dr. Darwan Madja Purba, SpM(K) as ultimate beneficial owner of the Company.
Selengkapnya di halaman JECX →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →